05/09/2024
3:18 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form ARS | |
05/09/2024
7:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
3:21 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B3 | |
04/17/2024
11:15 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form EFFECT | |
04/12/2024
3:15 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form POS AM | |
04/12/2024
3:15 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form POS AM | |
04/01/2024
7:16 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
03/28/2024
3:30 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:30 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
4:37 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024
3:18 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B3 | |
03/10/2024
11:15 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form EFFECT | |
03/04/2024
7:06 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
7:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2024
7:11 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
10:11 AM | Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SC 13D/A | |
02/15/2024
3:15 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B5 | |
02/15/2024
3:18 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
4:00 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 3/A | |
01/25/2024
4:00 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 3/A | |
01/22/2024
7:01 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:43 PM | Lewis William (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
6:40 PM | Lewis William (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2024
7:21 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
7:08 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
4:26 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:17 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:17 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:19 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
van der Kamp Hilde Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:21 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:10 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:13 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Smither John W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:14 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:04 PM | Downing Nicholas (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
4:09 PM | Bain Capital Life Sciences Fund II, L.P. (Reporting)
Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors II, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
BCIP Life Sciences Associates, LP (Reporting)
BCLS Fund III Investments GP, LLC (Reporting)
BCLS Fund III Investments, LP (Reporting)
BCLS II Investco , LLC (0001819101) (Reporting)
BCLS II Investco, LP (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
van der Kamp Hilde Johanna (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Slootweg Hugo Alexander (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Read this before you buy AI stocks (Ad) BREAKING: New "Formula" Could Lead to Huge AI Payouts
When you click here and see what Elon Musk's new invention does…
Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. |
12/29/2023
3:30 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Topper James N (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
Smither John W (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/19/2023
11:15 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form EFFECT | |
12/19/2023
3:36 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B3 | |
11/13/2023
7:22 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2023
7:24 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B3 | |
10/23/2023
7:12 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2023
7:10 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/21/2023
6:14 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/21/2023
6:18 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B3 | |
09/19/2023
8:30 PM | Morningside Venture Investments Ltd (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SC 13G/A | |
08/15/2023
3:52 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B3 | |
08/14/2023
3:52 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/13/2023
11:15 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form EFFECT | |
08/07/2023
6:56 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form POS AM | |
08/07/2023
6:24 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2023
6:38 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2023
3:30 PM | NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
07/07/2023
4:00 PM | Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SC 13D | |
07/07/2023
4:06 PM | Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SC 13D/A | |
06/21/2023
3:01 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2023
3:04 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B3 | |
06/20/2023
3:30 PM | NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G | |
06/13/2023
4:04 PM | BCLS II Investco, LP (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SC 13D/A | |
06/09/2023
8:39 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/09/2023
8:43 PM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B3 | |
06/09/2023
2:47 PM | Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma Co N.V. (Subject)
NewAmsterdam Pharma (Subject)
| Form SC 13D/A | |
06/05/2023
7:50 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2023
7:00 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2023
7:11 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2023
7:14 AM | NewAmsterdam Pharma Co N.V. (Filer)
NewAmsterdam Pharma (Filer)
| Form 424B3 | |
